Wockhardt Receives Tentative FDA Approval For Memantine
Wockhardt has received tentative approval from the FDA for marketing the 5mg and 10mg tablets of Memantine HCI, which is used for treatment of moderate to severe Alzheimer’s
Pacira BioSciences has entered into an exclusive agreement with Italian pharmaceutical company Molteni Farmaceutici to distribute and commercialise Exparel across the EU and the UK.
The European Commission has granted marketing approval for BioMarin’s 3,4-diaminopyridine (amifampridine phosphate), for the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). Reportedly, Amifampridine phosphate, developed by the
Pearl Therapeutics has announced positive results from a phase 2a dose-ranging study of PT001, the company’s glycopyrrolate hydrofluoroalkane metered dose inhaler (HFA-MDI) formulation. The data showed that PT001